Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Feihe Limited ( (HK:6186) ) has issued an update.
China Feihe Limited reported a challenging 2025 financial year, with revenue falling 12.7% to RMB18.11 billion and gross profit declining 14.5% to RMB11.78 billion. Profit for the year dropped 42.7% to RMB2.09 billion, reflecting weaker operating performance despite broadly stable selling and administrative expenses.
Earnings per share were nearly halved to RMB0.21, underscoring the pressure on shareholder returns amid softer profitability. The board nonetheless proposed a lower final dividend and highlighted that an interim dividend of about RMB1 billion was already paid in September, signalling an ongoing but more cautious capital return policy in a tougher market environment.
The most recent analyst rating on (HK:6186) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.
More about China Feihe Limited
China Feihe Limited is a China-based dairy company focused on the production and sale of infant formula and related dairy products. Listed in Hong Kong, the group targets the domestic market with branded, higher-end nutritional offerings aimed at Chinese families and children.
Average Trading Volume: 20,192,046
Technical Sentiment Signal: Sell
Current Market Cap: HK$34.42B
See more data about 6186 stock on TipRanks’ Stock Analysis page.